Literature DB >> 22842831

Vascular mild cognitive impairment: concept, definition, and directions for future studies.

Arturo Consoli1, Marco Pasi, Leonardo Pantoni.   

Abstract

Vascular mild cognitive impairment (vascular MCI) describes an abnormal condition which is caused by vascular diseases and in which the patient presents with cognitive deficits not severe enough to fit the criteria for dementia (i.e., basic functional autonomy is not lost). As in neurodegenerative MCI, the clinical, neuroimaging, and natural history features of vascular MCI are currently under definition. It is particularly important to identify cognitive impairment of vascular origin during the early stages, as its progression may be slowed or halted by intervening with aggressive treatment of vascular risk factors and diseases. Longitudinal studies on the natural history of vascular MCI, with investigation of the factors responsible for the transition to dementia, are worthy of being planned and carried out.

Entities:  

Mesh:

Year:  2012        PMID: 22842831     DOI: 10.1007/bf03325158

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  13 in total

Review 1.  [Cognitive deficits in unipolar major depression].

Authors:  C Konrad; S Losekam; M Zavorotnyy
Journal:  Nervenarzt       Date:  2015-01       Impact factor: 1.214

2.  Coronary artery disease and plasma apolipoprotein E4 in mild cognitive impairment.

Authors:  Majid Barekatain; Faezeh Zahedian; Hedyeh Askarpour; Mohammad Reza Maracy; Mohammad Hashemi-Jazi; Mohammad Reza Aghaye-Ghazvini
Journal:  ARYA Atheroscler       Date:  2014-09

3.  Association between Carotid Artery Stenosis and Cognitive Impairment in Stroke Patients: A Cross-Sectional Study.

Authors:  Wei Yue; Anxin Wang; Runxiu Zhu; Zhongrui Yan; Shouhuan Zheng; Jingwei Wang; Jia Huo; Yunlin Liu; Xin Li; Yong Ji
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

Review 4.  Vascular Contributions to Cognitive Impairment and Treatments with Traditional Chinese Medicine.

Authors:  Xinhua Zhou; Guozhen Cui; Hisa Hui Ling Tseng; Simon Ming-Yuen Lee; George Pak Heng Leung; Shun Wan Chan; Yiu Wa Kwan; Maggie Pui Man Hoi
Journal:  Evid Based Complement Alternat Med       Date:  2016-11-23       Impact factor: 2.629

5.  Severe carotid artery stenosis evaluated by ultrasound is associated with post stroke vascular cognitive impairment.

Authors:  Xuefeng Li; Xiangling Ma; Jing Lin; Xiangqin He; Feng Tian; Dongmei Kong
Journal:  Brain Behav       Date:  2016-11-22       Impact factor: 2.708

6.  Diagnostic Values of Serum Levels of Homocysteine and Uric Acid for Predicting Vascular Mild Cognitive Impairment in Patients with Cerebral Small Vessel Disease.

Authors:  Ting Wang; Zhong-Wu Sun; Liang-Qing Shao; Xiao-Bin Xu; Yang Liu; Mao Qin; Xiang Weng; Yong-Xiang Zhang
Journal:  Med Sci Monit       Date:  2017-05-10

7.  Effect of Yin-Xing-Tong-Zhi Tablets on Improving Vascular Cognitive Impairment No Dementia.

Authors:  Weidong Pan; Wei Zhu; Qi Gao; Weilong Liao; Penglin Gao; Te Liu
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-26       Impact factor: 2.629

8.  Effect of Pushen capsule for treating vascular mild cognitive impairment: a pilot observational study.

Authors:  Shuo Li; Geyin Cao; Qiwen Deng; Dan Zhu; Fuling Yan
Journal:  J Int Med Res       Date:  2019-08-13       Impact factor: 1.671

9.  A score based on screening tests to differentiate mild cognitive impairment from subjective memory complaints.

Authors:  Fábio Henrique de Gobbi Porto; Lívia Spíndola; Maira Okada de Oliveira; Patrícia Helena Figuerêdo do Vale; Marco Orsini; Ricardo Nitrini; Sonia Maria Dozzi Brucki
Journal:  Neurol Int       Date:  2013-09-05

10.  Distinguishing mild cognitive impairment from healthy aging and Alzheimer's Disease: The contribution of the INECO Frontal Screening (IFS).

Authors:  Helena S Moreira; Ana Sofia Costa; Álvaro Machado; São Luís Castro; César F Lima; Selene G Vicente
Journal:  PLoS One       Date:  2019-09-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.